CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +598 | $58.06 | $35K | 33,798 |
| 2025-09-02 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −598 | $84.97 | $51K | 33,200 |
| 2025-09-02 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −598 | 14,962 | ||
| 2025-08-25 | Basi Ramitpal K EVP, Human Resources | Grant or award | +6,506 | 6,506 | ||
| 2025-08-25 | Basi Ramitpal K EVP, Human Resources | Grant or award · Performance Shares | +16,265 | 16,265 | ||
| 2025-08-25 | Basi Ramitpal K EVP, Human Resources | Grant or award · Employee Stock Option (right to buy) | +29,230 | 29,230 | ||
| 2025-08-15 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +277 | $64.25 | $18K | 33,477 |
| 2025-08-15 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −277 | $86.81 | $24K | 33,200 |
| 2025-08-15 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −277 | 9,716 | ||
| 2025-08-04 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +598 | $58.06 | $35K | 33,798 |
| 2025-08-04 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −598 | $75.77 | $45K | 33,200 |
| 2025-08-04 | Denton Sheila A. EVP & General Counsel | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −598 | 15,560 | ||
| 2025-07-21 | Stein Steven H EVP & Chief Medical Officer | Sale 10b5-1 | −3,706 | $67.94 | $252K | 102,886 |
| 2025-07-16 | Flannelly Barry P EVP & General Manager US | Sale 10b5-1 | −1,340 | $68.36 | $92K | 35,149 |
| 2025-07-16 | Iyengar Vijay K EVP, GMAPPS | Sale 10b5-1 | −983 | $68.36 | $67K | 40,540 |
| 2025-07-16 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −785 | $68.36 | $54K | 33,200 |
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Option exercise 10b5-1 | +3,330 | $64.25 | $214K | 29,834 |
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Sale 10b5-1 | −3,330 | $69.86 | $233K | 26,504 |
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Shares withheld for taxes 10b5-1 | −703 | $68.25 | $48K | 25,801 |
| 2025-07-15 | Denton Sheila A. EVP & General Counsel | Grant or award 10b5-1 | +8,184 | 33,985 |
Page 16 of 25 · 500 trades